Literature DB >> 1618238

Scintigraphic evaluation of the pharmacokinetics of a soluble polymeric drug carrier.

M V Pimm1, A C Perkins, F Hudecz.   

Abstract

There is a growing interest in the use of macro-molecular carriers for therapeutic agents. If these carriers can be labelled with an appropriate gamma-emitter, their biodistribution could be followed by scintigraphy. We have imaged the biodistribution of a synthetic branched polypeptide, based on a poly-L-lysine backbone (average molecular mass 45 kDa). The polymer was conjugated to diethylene triamine penta-acetic acid and labelled by chelation with indium-111. Mice were injected i.v. with labelled material and imaged with a gamma-camera with a pin-hole collimator. Images showed the majority of tracer remaining in the blood pool, but about 35% appeared in the urinary bladder within 1.5 h. When the 111In-polymer was fractionated by gel filtration chromatography on S-300, the imaging showed that the early eluting material was retained, the intermediate showed some renal clearance, and the late was rapidly excreted. These findings show the value of gamma-scintigraphy for biodistribution studies with such polymeric drug carriers and its potential for clinical pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618238     DOI: 10.1007/bf00177374

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  8 in total

1.  Carrier design: biodistribution of branched polypeptides with a poly(L-lysine) backbone.

Authors:  J A Clegg; F Hudecz; G Mezö; M V Pimm; M Szekerke; R W Baldwin
Journal:  Bioconjug Chem       Date:  1990 Nov-Dec       Impact factor: 4.774

2.  Demonstration of the hepatic uptake of radiolabelled immunotoxins using gamma scintigraphy.

Authors:  A C Perkins; M V Pimm; R W Baldwin
Journal:  Eur J Cancer Clin Oncol       Date:  1987-08

Review 3.  Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.

Authors:  L W Seymour; R Duncan; P Kopecková; J Kopecek
Journal:  Cancer Treat Rev       Date:  1987-12       Impact factor: 12.111

4.  A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts.

Authors:  S M Andrew; A C Perkins; M V Pimm; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1988

5.  Synthesis, conformation, biodistribution, and in vitro cytotoxicity of daunomycin-branched polypeptide conjugates.

Authors:  F Hudecz; J A Clegg; J Kajtár; M J Embleton; M Szekerke; R W Baldwin
Journal:  Bioconjug Chem       Date:  1992 Jan-Feb       Impact factor: 4.774

6.  Influence of side-chain-terminating moieties on the conformation of branched polypeptides and their conjugates with 4-ethoxymethylene-2-phenyl-5(4H)-oxazolone.

Authors:  F Hudecz; J Kajtár; M Szekerke
Journal:  Biophys Chem       Date:  1988-08       Impact factor: 2.352

7.  The pharmacokinetics of polymer-bound adriamycin.

Authors:  L W Seymour; K Ulbrich; J Strohalm; J Kopecek; R Duncan
Journal:  Biochem Pharmacol       Date:  1990-03-15       Impact factor: 5.858

8.  N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.

Authors:  L W Seymour; K Ulbrich; S R Wedge; I C Hume; J Strohalm; R Duncan
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

  8 in total
  3 in total

1.  Gamma scintigraphy of 111In-labelled branched chain polypeptides (BCP) with a poly(L-lysine) backbone in mice with mammary carcinoma: effect of charge on biodistribution and tumour imaging potential.

Authors:  M V Pimm; A C Perkins; S J Gribben; G Mezö; D Gaál; F Hudecz
Journal:  Ann Nucl Med       Date:  1995-11       Impact factor: 2.668

2.  Experimental biodistribution studies of 99mTc-recombinant human serum albumin (rHSA): a new generation of radiopharmaceutical.

Authors:  A C Perkins; M Frier
Journal:  Eur J Nucl Med       Date:  1994-11

3.  Biodistribution in tumour-bearing mice of polycationic, amphoteric and polyanionic branched polypeptides with a poly(L-lysine) backbone labelled with 125I and 111In: tumour accumulation less than that of labelled serum proteins.

Authors:  M V Pimm; F Hudecz
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.